Medidata will receive and process medical-grade sensor data within drug, vaccine, and device trials across Labcorp's drug development clinical trial portfolio.

Additionally, the companies will use the digital health technology data platform to co-develop digital biomarkers across an array of medical devices and therapeutic areas. The platform will utilize Mediadata's Sensor Cloud platform to process sensor data and establish interoperability with other clinical data sources.

The goal of the partnership is to build a library of digital biomarkers that can be used to advance therapeutic research and diagnostics. The first project will be an at-home version of the six-minute walk test, which is used in clinics to measure functional capacity in patients with heart failure, pulmonary conditions, physical function disorders, and rare diseases.

Labcorp, CCORN collaborate to understand cancer disparities
Labcorp is collaborating with the Community Clinical Oncology Research Network (CCORN) to better understand the impact of disparities in precision medicine...

Medidata offers trial decentralization platform
Medidata has launched an end-to-end unified platform for the decentralization of clinical trials.

Medidata debuts patient engagement registries for clinical trials
Medidata has expanded its myMedidata patient portal with myMedidata Registries, a new technology designed to facilitate engagement with patients before...